Product NDC: | 0078-0367 |
Proprietary Name: | Famvir |
Non Proprietary Name: | famciclovir |
Active Ingredient(s): | 250 mg/1 & nbsp; famciclovir |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0367 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020363 |
Marketing Category: | NDA |
Start Marketing Date: | 19940629 |
Package NDC: | 0078-0367-15 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0078-0367-15) |
NDC Code | 0078-0367-15 |
Proprietary Name | Famvir |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0078-0367-15) |
Product NDC | 0078-0367 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | famciclovir |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19940629 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | FAMCICLOVIR |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |